A 26‐year‐old man presented to the emergency department (ED) overnight with severe and disabling abdominal pain. On initial assessment, he described sudden onset sharp pain in the right iliac fossa 6 hours earlier, with subsequent generalisation across the abdomen and the development of nausea and vomiting, subjective fevers, profuse diaphoresis and pleuritic chest pain. On examination, there was general abdominal discomfort without rebound tenderness; clinical observations and the remainder of the examination were unremarkable. Basic investigations demonstrated a normal full blood count, electrolytes and liver function tests. The history and examination were not typical of an acute abdomen, appendicitis or cholecystitis. The patient provided a past medical history notable for gastro‐oesophageal reflux disease and a diagnosis of irritable bowel syndrome following a normal colonoscopy with a gastroenterologist. Intravenous analgesia was provided and resulted in symptomatic improvement.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Masatlioglu S, Dulundu E, Gogus F, et al. The frequency of familial Mediterranean fever in an emergency unit. Clin Exp Rheumatol 2011; 29 (Suppl): S44–S46.
- 2. Livneh A, Langevitz P, Zemer D, et al. Criteria for the diagnosis of familial mediterranean fever. Arthritis Rheum 1997; 40: 1879–1885.
- 3. Federici S, Sormani MP, Ozen S, et al. Evidence‐based provisional clinical classification criteria for autoinflammatory periodic fevers. Ann Rheum Dis 2015; 74: 799–805.
- 4. Giancane G, Ter Haar NM, Wulffraat N, et al. Evidence‐based recommendations for genetic diagnosis of familial Mediterranean fever. Ann Rheum Dis 2015; 74: 635–641.
- 5. Booty MG, Chae JJ, Masters SL, et al. Familial Mediterranean fever with a single MEFV mutation: where is the second hit? Arthritis Rheum 2009; 60: 1851–1861.
- 6. Touitou I. The spectrum of familial Mediterranean fever (FMF) mutations. Eur J Hum Genet 2001; 9: 473–483.
- 7. Wu B, Xu T, Li Y, Yin X. Interventions for reducing inflammation in familial Mediterranean fever. Cochrane Database Syst Rev 2018; (10): CD010893.
- 8. Padeh S, Yackov B. Familial Mediterranean fever. Curr Opin Rheumatol 2016; 28: 523–529.
- 9. Ozen S, Demirkaya E, Erer B, et al. EULAR recommendations for the management of familial Mediterranean fever. Ann Rheum Dis 2016; 75: 644–651.
- 10. Twig G, Livneh A, Vivante A, et al. Mortality risk factors associated with familial Mediterranean fever among a cohort of 1.25 million adolescents. Ann Rheum Dis 2014; 73: 704–709.
No relevant disclosures.